drugset / Trial / NCT00749788
Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the effect of JTT-302 on the increase of High Density Lipoprotein-Cholesterol (HDL-C) levels when administered daily for four weeks in subjects with low HDL-C levels.
Timeline
- Start
- 2006-12
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JTT-302 | Unknown | 200 mg | Oral |
| Subject | JTT-302 | Unknown | 400 mg | Oral |